New Findings;Ebola Vaccines Discovered to be 100% Effective

  • comments
  • print
  • email
Dec 26, 2016 07:14 AM EST

After a long search for a cure to a deadly virus; finally, new findings can give assurance to victims. The World Health Organization have released a vaccine against the fatal Ebola virus and have discovered to be 100% effective which give hope to the infected country.

In 1976, Ebola first appears in Sudan and Zaire that infected over 280 persons which cause the mortality rate of 53%. And this disease was devastated at West Africa in 2014 that caused the killing more than 11,000 people.

The outcome was published in The Lancet medical journal and almost 6,000 patient had received the vaccine. After 10 days the victims were declared free from the infection while the other group who did not receive any treatment had 23 cases developed Ebola, according to BBC.

The director of the national agency for health security in Guinea, Dr. Kelta Sakoba and his team stated how proud they are of being able to contribute a developing vaccine that will help other nations to lessen out the Ebola victims like what they endured.

According to CNN, the experimental vaccine was distributed in 2015 to people in Guinea that had been attaching to patients. But people over the age of 18 was selected for the medication and the contestant will randomly undergo the treatment.   

Meanwhile, some people who take the vaccine was reportedly met reaction, such as fatigue, muscle pain, and headache. But there is two patient had the serious cases that involve an allergic reaction.

The vaccine will be manufactured by Merck, Sharp & Dohme facilitated by US and European regulatory agencies. In the other hand, Merck guaranteed to make 300,000 doses of vaccine that is available for any Ebola cases breakout.

The remedy was developed in Canada and might be obtainable by 2018. Dr. Kieny, assistant director-general and the study's lead author of WHO stated that they have the prevention to the disease and "one step quicker" than the spreading disease. 

Join the Conversation
Real Time Analytics